Metraipolis › archive › dc_0108262176ae

Symmetric vaccine efficacy — Europe PMC PMID:42578828

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42578828
DOI
10.1093/biomtc/ujag141
License (as archived)
solo-consultazione
Archived
2026-10-08T10:00:37.270Z
SHA-256 of the archived text
ce3845c19ffb980986c6ce87bea25899a079686a63f17404c633d225b5748c0b
Stable URL of this page
https://metraipolis.com/documento/dc_0108262176ae

How to cite

Symmetric vaccine efficacy — Europe PMC PMID:42578828 — Europe PMC (en), https://europepmc.org/article/MED/42578828 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0108262176ae (Metraipolis archive dc_0108262176ae, sha256 ce3845c19ffb980986c6ce87bea25899a079686a63f17404c633d225b5748c0b)
BibTeX
@misc{dc0108262176ae,
  title = {Symmetric vaccine efficacy — Europe PMC PMID:42578828},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42578828},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0108262176ae; sha256 ce3845c19ffb980986c6ce87bea25899a079686a63f17404c633d225b5748c0b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42578828. Agents can read the archived copy with the MCP tool read_document.